In: Atlas of Geriatric Dermatology
This persistent immune activation isn't just a symptom
Antimicrobial peptides are being developed to address the growing problem of antibiotic resistance
This injection should only be administered by a healthcare professional and should not be self-administered at home
The primary composite outcome of major adverse cardiac events plus (MACE+), including death from CV causes, nonfatal MI, and hospitalization for unstable angina, was reached in 13.4% of patients in the lixisenatide group and 13.2% of patients in placebo group, demonstrating noninferiority, but not superiority, of lixisenatide compared with placebo
3 Custom Protocol Your physician designs a IV Drip Therapy protocol matched to your lab results, lifestyle, and goals